AAAAAA
Results: 1001-1025/15678
Authors:
Bock, CT
Tillmann, HL
Manns, MP
Trautwein, C
Citation: Ct. Bock et al., The pre-S region determines the intracellular localization and appearance of hepatitis B virus, HEPATOLOGY, 30(2), 1999, pp. 517-525
Authors:
Edwards-Smith, CJ
Jonsson, JR
Purdie, DM
Bansal, A
Shorthouse, C
Powell, EE
Citation: Cj. Edwards-smith et al., Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa, HEPATOLOGY, 30(2), 1999, pp. 526-530
Authors:
Heathcote, J
McHutchison, J
Lee, S
Tong, M
Benner, K
Minuk, G
Wright, T
Fikes, J
Livingston, B
Sette, A
Chestnut, R
Citation: J. Heathcote et al., A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus, HEPATOLOGY, 30(2), 1999, pp. 531-536
Authors:
Mondelli, MU
Cerino, A
Lisa, A
Brambilla, S
Segagni, L
Cividini, A
Bissolati, M
Missale, G
Bellati, G
Meola, A
Bruniercole, B
Nicosia, A
Galfre, G
Silini, E
Citation: Mu. Mondelli et al., Antibody responses to hepatitis C virus hypervariable region 1: Evidence for cross-reactivity and immune-mediated sequence variation, HEPATOLOGY, 30(2), 1999, pp. 537-545
Authors:
Lau, DTY
Doo, E
Park, Y
Kleiner, DE
Schmid, P
Kuhns, MC
Hoofnagle, JH
Citation: Dty. Lau et al., Lamivudine for chronic delta hepatitis, HEPATOLOGY, 30(2), 1999, pp. 546-549
Authors:
Ware, JE
Bayliss, MS
Mannocchia, M
Davis, GL
Citation: Je. Ware et al., Health-related quality of life in chronic hepatitis C: Impact of disease and treatment response, HEPATOLOGY, 30(2), 1999, pp. 550-555
Authors:
Sakai, A
Kaneko, S
Honda, M
Matsushita, E
Kobayashi, K
Citation: A. Sakai et al., Quasispecies of hepatitis C virus in serum and in three different parts ofthe liver of patients with chronic hepatitis, HEPATOLOGY, 30(2), 1999, pp. 556-561
Authors:
Heathcote, EJL
James, S
Mullen, KD
Hauser, SC
Rosenblate, H
Albert, DG
Citation: Ejl. Heathcote et al., Chronic hepatitis C virus patients with breakthroughs during interferon treatment can successfully be retreated with consensus interferon, HEPATOLOGY, 30(2), 1999, pp. 562-566
Authors:
Liaw, YF
Chien, RN
Yeh, CT
Tsai, SL
Chu, CM
Citation: Yf. Liaw et al., Acute exacerbation and hepatitis B virus clearance after emergence of YMDDmotif mutation during lamivudine therapy, HEPATOLOGY, 30(2), 1999, pp. 567-572
Authors:
Wogan, GN
Citation: Gn. Wogan, Aflatoxin as a human carcinogen, HEPATOLOGY, 30(2), 1999, pp. 573-575
Authors:
Patel, T
Citation: T. Patel, Immune escape in hepatocellular cancer: Is a good offense the best defense?, HEPATOLOGY, 30(2), 1999, pp. 576-578
Authors:
Malik, AH
Lee, WM
Citation: Ah. Malik et Wm. Lee, Hepatitis B therapy: The plot thickens, HEPATOLOGY, 30(2), 1999, pp. 579-581
Authors:
Schwarzenberg, SJ
Citation: Sj. Schwarzenberg, Congenital hepatic fibrosis - Is it really a matter of "a spoonful of sugar?" - Comments, HEPATOLOGY, 30(2), 1999, pp. 582-582
Authors:
Schwarzenberg, SJ
Citation: Sj. Schwarzenberg, Congenital hepatic fibrosis - Is it really a matter of "a spoonful of sugar?" - Comments, HEPATOLOGY, 30(2), 1999, pp. 582-583
Authors:
Cargnel, A
Gubertini, G
Mangnani, C
Bosis, S
Colombo, F
Clerici, M
Citation: A. Cargnel et al., Immune response in chronic hepatitis C-infected patients undergoing interferon treatment, HEPATOLOGY, 30(2), 1999, pp. 584-585
Authors:
Balik, I
Yilmaz, N
Turkcapar, N
Yasa, H
Citation: I. Balik et al., Association of diabetes mellitus and chronic hepatitis C virus infection, HEPATOLOGY, 30(2), 1999, pp. 584-584
Authors:
Mason, AL
Alexander, GM
Perrillo, RP
Citation: Al. Mason et al., Association of diabetes mellitus and chronic hepatitis C virus infection -Reply, HEPATOLOGY, 30(2), 1999, pp. 584-584
Authors:
Le Bail, B
Carles, J
Saric, J
Balabaud, C
Bioulac-Sage, P
Citation: B. Le Bail et al., Ectopic liver and hepatocarcinogenesis, HEPATOLOGY, 30(2), 1999, pp. 585-586
Authors:
Ghent, CN
Citation: Cn. Ghent, The pruritus of cholestasis, HEPATOLOGY, 30(2), 1999, pp. 586-586
Authors:
Jones, EA
Bergasa, NV
Citation: Ea. Jones et Nv. Bergasa, The pruritus of cholestasis - Reply, HEPATOLOGY, 30(2), 1999, pp. 586-587
Authors:
Clemens, MG
Citation: Mg. Clemens, Nitric oxide in liver injury, HEPATOLOGY, 30(1), 1999, pp. 1-5
Authors:
Tomida, S
Abei, M
Yamaguchi, T
Matsuzaki, Y
Shoda, J
Tanaka, N
Osuga, T
Citation: S. Tomida et al., Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: Acohort analysis, HEPATOLOGY, 30(1), 1999, pp. 6-13
Authors:
Kallien, G
Lange, K
Stange, EF
Scheibner, J
Citation: G. Kallien et al., The pravastatin-induced decrease of biliary cholesterol secretion is not directly related to an inhibition of cholesterol synthesis in humans, HEPATOLOGY, 30(1), 1999, pp. 14-20
Authors:
Palmer, JM
Jones, DEJ
Quinn, J
McHugh, A
Yeaman, SJ
Citation: Jm. Palmer et al., Characterization of the autoantibody responses to recombinant E3 binding protein (Protein X) of pyruvate dehydrogenase in primary biliary cirrhosis, HEPATOLOGY, 30(1), 1999, pp. 21-26
Authors:
Stephens, J
Cosyns, M
Jones, M
Hayward, A
Citation: J. Stephens et al., Liver and bile duct pathology following Cryptosporidium parvum infection of immunodeficient mice, HEPATOLOGY, 30(1), 1999, pp. 27-35